Week in Review: Study Shows Substance Use Disorders Possibly Linked to COVID-19


Top news of the week from Pharmacy Times®.

Top news of the week from Pharmacy Times®.

5. Practicing Mindfulness May Help to Reduce Heart Attack, Stroke

Practicing mindfulness in conjunction with lifestyle changes, such as weight loss and salt reduction, can help treat and prevent high blood pressure, according to a new hypothesis published in Medical Hypotheses. Read more.

4. Study: Babies Born in Fall at Higher Risk for Allergic Diseases

New research suggests that infants born in the fall may have a higher risk for allergic diseases such as eczema, food allergies, asthma, and hay fever. Read more.

3. Clinical Features of COVID-19 Versus Seasonal Influenza A, B in US Children

A new study published in JAMA suggests that prevention of both coronavirus disease 2019 (COVID-19) and seasonal influenza in US children is sensible and important for the well-being of the population. Read more.

2. Emergency Medications for Inpatient Treatment of COVID-19 Patients

The emergency use of these drugs to shorten hospitalization and prolong time for vaccine research and development will serve as a critical temporary buffer for an efficient vaccine to combat severe acute respiratory syndrome coronavirus 2. Read more.

1. Study: Substance Use Disorders Possibly Linked to COVID-19

Researchers at the National Institutes of Health have found that individuals with substance use disorders (SUD) were more likely than those without a SUD to develop COVID-19. Read here.

Related Videos
Emergency CPR on a Man who has Heart Attack , One Part of the Process Resuscitation (First Aid) - Image credit: Platoo Studio | stock.adobe.com
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Image Credit: Pixel-Shot | stock.adobe.com
3D illustration of heart
Model of a heart
Man experiencing heart pain
3D illustration of heart
Image credit: terovesalainen - stock.adobe.com
ipopba - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.